Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome. - Gao Z; Yang F; Pan H; Zhang L; Li W; Li R; Zhao J; Luo Y; Yu X; Kuang Z; Nie N; Li J; et al. (Annals of hematology, 2026)